Company Filing History:
4 out of 1,384 
2 out of 16 
2 out of 7 Years Active: 1999-2016
Title: Ludger Dinkelborg: Innovator in Radiopharmaceuticals
Introduction
Ludger Dinkelborg is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 10 patents. His work focuses on the development of compounds that are crucial for medical imaging and therapeutic applications.
Latest Patents
Dinkelborg's latest patents include innovative compounds such as [F-18]-labeled L-glutamic acid and [F-18]-labeled L-glutamine. These patents describe the synthesis and applications of these compounds, which are essential for various medical uses. The compounds and their derivatives are outlined in detail, showcasing their potential in enhancing diagnostic imaging.
Career Highlights
Throughout his career, Ludger Dinkelborg has worked with notable companies, including Schering Aktiengesellschaft and Piramal Imaging. His expertise in the field has led to advancements in the development of radiopharmaceuticals, making significant impacts on medical diagnostics.
Collaborations
Dinkelborg has collaborated with esteemed colleagues such as Friedhelm Blume and Christoph-Stephan Hilger. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Ludger Dinkelborg's contributions to the field of radiopharmaceuticals are noteworthy, with a strong portfolio of patents that reflect his innovative spirit. His work continues to influence advancements in medical imaging and therapy.